Thursday, September 17, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.6
The FTSE 100 shows a bifurcated tape: a broad swath of consumer, healthcare-device, staples and REIT names are down sharply over the past month (Smith & Nephew, JD Sports, Babcock, Entain, Rentokil, Land Securities all off double digits), while pockets of financials, miners/energy and telecoms are pushing toward 52-week highs on sustained 5- and 30-day momentum. No fresh news feed was available, so this analysis leans entirely on price-momentum and 52-week-high proximity as the catalyst proxy.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | NWG.L | SKIP | — | £712.80 → £748.45 stop £655.78 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | GSK.L | SKIP | — | £1,900.00 → £1,995.00 stop £1,774.60 |
Position cap reached — 86 of 20 slots in use. |
| #3 | CCH.L | SKIP | — | £4,610.00 → £4,840.50 stop £4,420.99 |
Position cap reached — 86 of 20 slots in use. |
Already open: ABBV (to Sep 19), EOG (to Sep 19), VRTX (to Sep 19), ADP (to Sep 19), MDLZ (to Sep 19), WBD (to Sep 19), BMY (to Sep 20), MSI (to Sep 20), PFE (to Sep 20), BT-A.L (to Sep 20), KDP (to Sep 20), COP (to Sep 23) … and 74 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
NatWest is one of the UK's largest high-street banks, offering current accounts, mortgages and business banking. Its share price has been climbing steadily, sits near a 52-week high, and is beating the wider market, with healthy (not overheated) technical readings backing further gains. The main risk is that bank stocks are highly sensitive to interest-rate expectations and economic-outlook news, which could quickly reverse the trend.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
GSK is a major global pharmaceutical and vaccines company. After a rough month, its shares have bounced back strongly in the last week and technical indicators show building strength without being overbought. The main risk is that drug-related news - a trial result, regulatory decision, or earnings surprise - can move a pharma stock sharply in either direction.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 61%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Coca-Cola HBC bottles and distributes Coca-Cola and other beverage brands across Europe and Africa. Its shares are gaining steady short-term momentum and technical signals point to a building move higher (a volatility squeeze that often precedes a breakout). The main risk is that consumer-staples companies like this can see margins squeezed by rising ingredient costs or currency swings.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 17, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 100 FTSE 100 constituents and short-listed 24 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.